The most costly expense that seed-stage biotechnology companies face in their early years is the initial expenditure on manufacturing equipment.

Question

Quizplus · Accepted Answer

The most costly expense for seed-stage biotechnology companies is typically research and development (R&D), not the initial expenditure on manufacturing equipment. R&D expenses cover a wide range of activities including laboratory studies, clinical trials, and other experiments necessary to develop new products or technologies.

The Most Costly Expense That Seed-Stage Biotechnology Companies Face in Their